BioArctic
BioArctic is a research-based biopharma company developing new treatments that address the causes of diseases that affect the central nervous system.
The company was founded in 2003 based on research from Uppsala University, Sweden.
BioArctic has partnerships in Alzheimer's disease with Japanese pharma major Eisai and in Parkinson's disease with the US drugmaker, AbbVie.
Latest BioArctic News & Features
28 June 2024
28 June 2024
26 June 2024
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze